News
After reviewing all the data and considering input from regulators, Pfizer decided to discontinue the danuglipron program.
Both the FDA and Novo Nordisk are advising patients and providers to check their supplies of Ozempic for counterfeit product. Individuals in possession of a counterfeit product are urged to call Novo ...
The Food and Drug Administration (FDA) has approved a tablet formulation of Livmarli ® (maralixibat).
The CDC has long urged vaccination for international travelers, but the recommendation for domestic travelers is a response to the ongoing outbreaks across the US.
Substantially elevated GAS incidence rates seen in people experiencing homelessness, people who inject drugs, long-term care facility residents ...
Major health groups, including Autism Speaks, agree that childhood vaccines do not cause autism. Autism is a developmental condition that can cause problems with language, learning and social skills.
Authors say these factors can inform steps individuals can take to lower their risks for age-related brain diseases.
HealthDay News — Among US adults without diabetes, the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) increased from 2018 to 2022, reaching annual prevalence of 0.4% in 2022, according ...
The Food and Drug Administration (FDA) has approved Opdivo ® (nivolumab) in combination with Yervoy ® (ipilimumab) for the first-line treatment of adult patients with unresectable or metastatic ...
After proper training on subcutaneous injection technique, the prefilled syringe may be administered by the patient or caregiver.
HealthDay News — Bausch + Lomb has announced a voluntary recall of intraocular lenses on its enVista platform due to the potential for an acute postoperative inflammatory reaction.
The delay dovetails with moves by Republican lawmakers in at least 7 states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results